Provided by Tiger Trade Technology Pte. Ltd.

Fractional Shares

2,042.95
+13.020.64%
Number of Gainers:691
Number of Losers:313
Number of Flat:15
PE:- -
High:2,044.72
Open:2,030.21
Low:2,030.21
Close:2,029.94
Volume:4.94B
Turnover:581.81B
Market Cap:97.58T
Float Cap:91.33T

Loading ...

Ansell Director Boosts Equity Stake Through Short-Term Incentive Award

TIPRANKS
·
Oct 08

Karoon Energy Posts Daily Update on Ongoing Share Buy-Back

TIPRANKS
·
Oct 08

Finder Energy presses toward FID on fast-track KTJ offshore oil project

TIPRANKS
·
Oct 08

PC Gold Plans New Share Placement to Raise Capital

TIPRANKS
·
Oct 08

IBM Advances to Stage C of Darpa Quantum Benchmarking Initiative

Reuters
·
Oct 08

Fredonia Mining Files NI 43-101 Technical Report for El Dorado-Monserrat Gold-Silver Project PEA

Reuters
·
Oct 08

Discovery Mining Reports New High-Grade Drill Intercepts Extending Pamour Mineralization Along Strike and at Depth

Reuters
·
Oct 08

Samsung profit up almost nine-fold with memory chip windfall

Yoolim Lee / Bloomberg
·
Oct 08

Alaska Airlines to Triple Global Routes with Help from Jal Partnership: CEO - Nikkei

THOMSON REUTERS
·
Oct 08

Alaska's Long-Haul International Routes Departing from Seattle Will Rise to 15 Destinations by 2030 - Nikkei

THOMSON REUTERS
·
Oct 08

Commodities Wrap: Crude Slips, Copper Edges Higher on Chile Strike Supply Fears, Gold Retreats

Deep News
·
Oct 08

SECUR3D Expands Sentry Marketplace Coverage and Raises Capital for Product Development

TIPRANKS
·
Oct 08

Exchange Traded Funds Top 10 Volume Leaders

Dow Jones
·
Oct 08

Tekedia Capital Flags Credit-Market Exposure Behind Nvidia’s $5.78 Trillion AI-Driven Valuation

Reuters
·
Oct 08

IBM advances to Stage C of DARPA Quantum Benchmarking Initiative

TIPRANKS
·
Oct 08

Medtronic - Exchange Ratio Set at 4.5939 Minimed Shares Per Medtronic Share

THOMSON REUTERS
·
Oct 08

Medtronic Sets Final 4.5939 Exchange Ratio in MiniMed Split-Off Offer

Reuters
·
Oct 08

IBM Advances to Stage C of DARPA Quantum Benchmarking Program for Fault-Tolerant Systems

Reuters
·
Oct 08

FDA feedback de-risks Noxopharm’s SOF-SKN Phase II trial plans

TIPRANKS
·
Oct 08

Intermap Forecasts 2027 Commercial Revenue of USD 12 Million-USD 15 Million, Adjusted Ebitda About USD 5 Million

Reuters
·
Oct 08